Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 35,350 KRW
Change Today +2,350 / 7.12%
Volume 1.6M
As of 2:25 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

komipharm international co (041960) Snapshot

Open
33,350
Previous Close
33,000
Day High
37,350
Day Low
32,200
52 Week High
05/22/15 - 37,350
52 Week Low
07/10/14 - 7,680
Market Cap
1.9T
Average Volume 10 Days
1.2M
EPS TTM
-44.00
Shares Outstanding
52.9M
EX-Date
03/23/07
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for KOMIPHARM INTERNATIONAL CO (041960)

Related News

No related news articles were found.

komipharm international co (041960) Related Businessweek News

No Related Businessweek News Found

komipharm international co (041960) Details

Komipharm International Co., Ltd. manufactures and sells veterinary vaccines, veterinary pharmaceuticals, natural extract food additives, and bio-fertilizers. The company offers vaccines for swine, cattle, poultry, and canine; chemicals, such as injectable antibiotics, antibacterial agents, multi-vitamin and essential amino acids injectable solution, and disinfectant for drinking water and livestock house, as well as chemicals for the treatment of pneumonia, arthritis, and septicemia; and natural extracts comprising grape fruit seed extracts. It also provides lab test services, including clinical diagnosis, examination, and assay. The company was formerly known as Korea Microbiological Laboratories Co., Ltd. and changed its name to Komipharm International Co., Ltd. in September 2004. Komipharm International Co., Ltd. was founded in 1972 and is headquartered in Siheung, South Korea.

Founded in 1972

komipharm international co (041960) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

komipharm international co (041960) Key Developments

Komipharm International Co., Ltd., Annual General Meeting, Mar 27, 2015

Komipharm International Co., Ltd., Annual General Meeting, Mar 27, 2015., at 10:00 Korea Standard Time. Agenda: To consider the approval of consolidated financial statements; to consider changes to articles of association; to consider the appointment of outside director; and to approve director remuneration.

Komipharm International Co., Ltd., Annual General Meeting, Mar 28, 2014

Komipharm International Co., Ltd., Annual General Meeting, Mar 28, 2014., at 10:00 Korea Standard Time. Location: 17 Place Gyeonggi Shiheung economy Co. headquarters conference room komipam. Agenda: To consider the approval of the financial statements and in the consolidated financial statements; to consider the appointment of standing auditor bakyigeun; to consider the approval of director remuneration; and to consider the approval of the remuneration.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
041960:KS 35,350.00 KRW +2,350

041960 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 041960.
View Industry Companies
 

Industry Analysis

041960

Industry Average

Valuation 041960 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 51.1x
Price/Book 33.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 51.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KOMIPHARM INTERNATIONAL CO, please visit www.komilab.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.